FT

Russia’s Sputnik vaccine shows 91.6% efficacy in clinical trials

Lancet peer review confirms performance of country’s flagship two-shot jab

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button